Narcolepsy and influenza vaccination-induced autoimmunity

Annals of Translational Medicine

Volumn 5, Issue 1, 2017, Pages

  Ahmed, S Sohail ^a   Steinman, Lawrence ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HEMAGGLUTININ; HLA DQB1 ANTIGEN; INFLUENZA VACCINE; NUCLEOPROTEIN; OREXIN 2 RECEPTOR; RECEPTOR ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY TITER; AUTOIMMUNITY; CROSS REACTION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNE RESPONSE; INFLUENZA A (H1N1); INFLUENZA A VIRUS (H1N1); INFLUENZA VACCINATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR WEIGHT; NARCOLEPSY; NERVE CELL; NONHUMAN; NOTE; PANDEMIC; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 85010677203     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.21037/atm.2016.12.63     Document Type: Note

References (19)

1. Nellore A, Randall TD. Narcolepsy and influenza vaccination-the inappropriate awakening of immunity. Ann Transl Med 2016;4:S29.
2. Ahmed SS, Volkmuth W, Duca J, et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 2015;7:294ra105.
3. Stowe J, Andrews N, Kosky C, et al. Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England. Sleep 2016;39:1051-7.
4. Ellis R, Rappuoli R, Ahmed S. Technologies for making new vaccines. In: Plotkin SA, Orenstein WA, Offit PA. editors. Vaccines. 6th edition. Edinburgh: Elsevier/Saunders, 2013:1182-99.
5. Ahmed SS, Montomoli E, Pasini FL, et al. The Safety of Adjuvanted Vaccines Revisited: Vaccine-Induced Narcolepsy. Isr Med Assoc J 2016;18:216-20.
6. Ahmed SS, Steinman L. Mechanistic insights into influenza vaccine-associated narcolepsy. Hum Vaccin Immunother 2016;12:3196-201.
7. Winstone AM, Stellitano L, Verity C, et al. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol 2014;56:1117-23.
8. Bui HH, Sidney J, Dinh K, et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 2006;7:153.
9. Hampe CS. B Cell in Autoimmune Diseases. Scientifica (Cairo) 2012;2012:1-18.
10. Vaarala O, Vuorela A, Partinen M, et al. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk. PLoS One 2014;9:e114361.
11. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-76.
12. Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
13. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-74.
14. Thannickal TC, Siegel JM, Nienhuis R, et al. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol 2003;13:340-51.
15. Mishima K, Fujiki N, Yoshida Y, et al. Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy. Sleep 2008;31:1119-26.
16. Wu MF, Nienhuis R, Maidment N, et al. Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy. J Neurosci 2011;31:6305-10.
17. Liblau RS, Vassalli A, Seifinejad A, et al. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol 2015;14:318-28.
18. Tafti M, Lammers GJ, Dauvilliers Y, et al. Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity. Sleep 2016;39:581-7.
19. Scammell TE. Narcolepsy. N Engl J Med 2015;373:2654-62